DAM
IMMU

DLD Asset Management’s Immunomedics Inc IMMU Stock Holding History

DLD Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,842,400
Closed -$40.6M – 112
2018
Q4 		$40.6M Buy
2,842,400
+213,600
+8% +$4.24M 2.78% 8
2018
Q3 		$54.8M Buy
2,628,800
+217,200
+9% +$5.14M 2.71% 8
2018
Q2 		$57.1M Buy
2,411,600
+253,200
+12% +$5.09M 4.3% 6
2018
Q1 		$31.5M Buy
2,158,400
+395,100
+22% +$6.46M 2.84% 11
2017
Q4 		$28.5M Buy
1,763,300
+1,043,000
+145% +$12.3M 2.07% 15
2017
Q3 		$10.1M Buy
720,300
+259,100
+56% +$2.58M 0.99% 23
2017
Q2 		$4.08M Buy
461,200
+354,000
+330% +$2.49M 0.53% 30
2017
Q1 		$692K Buy
+107,200
New +$543K 0.11% 35

DLD Asset Management's IMMU Position: Q4 2020 in Review

DLD Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 700,000 shares — an estimated $59.5M sold.

DLD Asset Management first reported a position in IMMU in Q4 2019 and held it in 2 quarters. The position peaked at $59.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • DLD Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • DLD Asset Management sold 700,000 Immunomedics Inc shares in Q4 2020, an estimated $59.5M.
  • DLD Asset Management first reported a position in Immunomedics Inc in Q4 2019 and held it in 2 quarters.
  • DLD Asset Management's Immunomedics Inc position peaked at $59.5M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on DLD Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.